February 25, 2014
Since announcing their major collaboration last year, OHSU and Intel have been hard at work launching their multi-year research and engineering initiative.
The alliance is developing next-generation computing technologies to advance the field of personalized medicine and drive scientific progress in understanding the genetic origins of illness. Collaborators are beginning with cancer but applications to personalized medicine will occur in multiple areas including neurological disorders, cardiovascular disease, rare diseases and others.
So what’s been happening lately? Engineers and scientists are building hardware, software and workflow solutions for Intel’s extreme-scale, high-performance computing solutions to address the unprecedented volume of complex biomedical data.
The team’s first projects are focused on genetic profiling of patients’ tumors to look for patterns in how the disease progresses and how to relate this information to how the tumor will respond to treatment.
By working together, the two institutions hope to dramatically increase the speed, precision and cost-effectiveness of analyzing a patient’s individual genetic profile.
To illustrate the effort, OHSU and Intel recently produced a video discussing the alliance’s goals with cancer.
Collaboration and innovative partnerships are centerpiece tenets of the School of Medicine Research Roadmap. A key Roadmap initiative is to support research collaborations such as the OHSU/Intel alliance and grow capacity in this area.